 The purpose of this study is to evaluate the safety and effectiveness of combination therapy with etanercept and narrow-band NB UVB phototherapy for the treatment of psoriasis in a pilot study. This is a Phase 4 clinical study being conducted under an Amgen Investigational New Drug Application IND. 